SBIR/STTR Research Award

THE GOAL OF THIS PROJECT IS TO DEVELOP SIMPLE AND RELIABLE BIOCHEMICAL TESTS WHICH CAN BE USED TO IDENTIFY INDIVIDUALS AT RISK FOR ALCOHOLISM, AND/OR TO ACCURATELY INDICATE RECENT ALCOHOL ABUSE.

Award identifier aa9cf7aa5bb0b5002d5a1550fbcf0f286953ad84d5fa8a37aca3ce2942faefbcAwarding agency Department of Health and Human Services

Award amount

$50,000

Program and phase

SBIR · Phase I

Award year

1984

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
Not reported
Recipient company
LOHOCLA RESEARCH CORPORATION
Proposal award date
Not reported
Contract end date
Not reported
UEI
E9QLNCNUDLE3
Solicitation number
Not reported
Topic code
Not reported

Research abstract

THE GOAL OF THIS PROJECT IS TO DEVELOP SIMPLE AND RELIABLE BIOCHEMICAL TESTS WHICH CAN BE USED TO IDENTIFY INDIVIDUALS AT RISK FOR ALCOHOLISM, AND/OR TO ACCURATELY INDICATE RECENT ALCOHOL ABUSE. IN PHASE I, THE FEASIBILITY OF USING PLATELET ENZYMES AS SUCH MARKERS WILL BE ASSESSED. OUR PRELIMINARY STUDIES HAVE INDICATED THAT CERTAIN CHARACTERISTICS OF PLATELET MONOAMINE OXIDASE (MAO) ACTIVITY (I.E., SENSITIVITY TO INHIBITION BY ETHANOL) AND ADENYLATE CYCLASE (AC) ACTIVITY ARE ALTERED IN ALCOHOLICS AS COMPARED TO CONTROLS. IN THE PROPOSED STUDIES, WE WILL CONFIRM THE DIFFERENCES IN A LARGER POPULATION AND DEVELOP RELIABLE METHODS FOR PLATELET PREPARATION AND ENZYME ASSAY WHICH WILL ACCENTUATE THESE DIFFERENCES. WE WILL ALSO EXAMINE ENZYME ACTIVITIES IN PLATELETS OBTAINED FROM ALCOHOLICS WHO HAVE ABSTAINED FROM ALCOHOL FOR VARIOUS LENGTHS OF TIME, IN ORDER TO DETERMINE WHETHER OBSERVED CHANGES IN PLATELET ENZYME ACTIVITIES RESULT FROM EXPOSURE TO ETHANOL, OR ARE INDICATIVE OF GENETICALLY-DETERMINED DIFFERENCES BETWEEN ALCOHOLICS AND CONTROL SUBJECTS. IN PHASE II, OUR CHOSEN ASSAY METHODS FOR MAO AND AC ACTIVITY WILL BE STREAMLINED FOR CLINICAL USE. THE REVERSIBILITY OF ENZYME CHANGES WILL BE FURTHER ASSESSED, AND ENZYME ACTIVITIES IN OTHER PSYCHIATRIC POPULATIONS (E.G., SCHIZOPHRENICS, OR PATIENTS WITH AFFECTIVE DISORDERS), AS WELL AS IN FEMALE ALCOHOLICS, WILL BE EXAMINED TO DETERMINE THE SPECIFICITY OF THESE TESTS FOR ALCOHOLISM OR ALCOHOL ABUSE. THE DEVELOPMENT OF SIMPLE AND RELIABLE TESTS FOR DIAGNOSING PAST ALCOHOL ABUSE OR A PREDISPOSITION TO ABUSE ALCOHOL WILL PROVIDE FOR THE PHYSICIAN: 1) A MEANS OF ASCERTAINING AN IMPORTANT CONTRIBUTING FACTOR TO MAJOR PATHOLOGIC CONDITIONS; 2) A MEANS OF ASSESSING PATIENT COMPLIANCE WITH INSTRUCTIONS TO TERMINATE ALCOHOL INTAKE; AND, 3) A POSSIBLE MEANS OF IDENTIFYING INDIVIDUALS AT RISK FOR DEVELOPING PROBLEMS WITH ALCOHOL IN THE FUTURE. EARLY IDENTIFICATION CAN ALLOW FOR EARLIER AND MORE EFFECTIVE INTERVENTION IN THE PATHOLOGY OF ALCOHOLISM.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

14 SBIR/STTR records share this UEI (1984–2024). Reported award amounts total $15,141,405. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.